Glycated hemoglobin of 7.2% in diabetic patients has not yet reached the control goal, is elevated, and may require medication if blood glucose control is unsatisfactory after treatment through diet and exercise. Specific glucose-lowering regimens should be consulted with a medical professional. Glycated hemoglobin is the product of combining hemoglobin in red blood cells and glucose in serum through non-enzymatic reaction. Because of its continuous, slow and irreversible characteristics, glycated hemoglobin can effectively reflect the average blood glucose level in the past 2~3 months. Glycated hemoglobin in diabetic patients generally needs to be controlled below 7%, so glycated hemoglobin of 7.2% is beyond the target range of control, and may need to be treated with glucose-lowering drugs such as metformin, acarbose, insulin and so on. Patients with diabetes should be treated under the guidance of a medical professional.